47 results on '"Pinacchio, Claudia"'
Search Results
2. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients
3. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients
4. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients
5. The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors
6. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women
7. Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients
8. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
9. Antiretroviral Therapy Dampens Mucosal CD4+ T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1
10. Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19
11. Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients
12. Fr576 ORAL BACTERIOTHERAPY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
13. Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study
14. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection
15. Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription
16. Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial
17. Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?
18. Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription
19. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection
20. Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action
21. Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
22. Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial
23. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients
24. Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study
25. Ozone as adjuvant support in the treatment of COVID‐19: A preliminary report of probiozovid trial.
26. BENEFICIAL EFFECT OF 6 MONTHS OF PROBIOTICS ON ASYMPTOMATIC NEUROCOGNITIVE IMPAIRMENT
27. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients
28. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS
29. Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation
30. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients
31. Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription.
32. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
33. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients
34. Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation
35. Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs)
36. Sa1854 - Oral Bacteriotherapy Improves Gut Inflammation and Reduces Fecal Infectivity of HIV Subjects
37. Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals
38. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals
39. Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus–Positive Patients: Preliminary Results of a New Study Approach
40. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women.
41. Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study
42. Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.
43. Antiretroviral Therapy Dampens Mucosal CD4 + T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1.
44. Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action.
45. Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients
46. Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial
47. Modulation of tryptophan/serotonin pathway by probiotic supplementation in human immunodeficiency virus-positive patients: preliminary results of a new study approach
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.